Tetracycline 250 mg powder kits packaged with powder and water in separate amber glass vials, with filter, in bag,…

Is this the product you have?

• Tetracycline 250 mg powder kits packaged with powder and water in separate amber glass vials, with filter, in bag, Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.

Lot codes and dates

• Lot Number
  • 07152014@50
  • Exp 10/13/2014
  • 07152014@54
  • Exp 10/13/2014
  • 07152014@55
  • Exp 10/13/2014
  • 07152014@56
  • Exp 10/13/2014
  • 07152014@48
  • Exp 10/13/2014
  • 07152014@49
  • Exp 10/13/2014
  • 08062014@53
  • Exp 11/4/2014

Amount recalled

7 kits

This recall covers 118 products

The agency filed one notice per product. You are reading one of them; the other 117 are below.

• Acetylcysteine 10% (PF) inhalant solution packaged in either a 3 mL or 7 mL vial…
• Acetylcysteine 20% (PF) inhalant solution packaged in either a 3 mL or 7 mL vial…
• Acetylcysteine 10% opthalmic solution packaged in an opaque squeeze bottle eye dropper…
• Alprostadil alcohol 500 mcg/mL injectable packaged in amber glass injectable vial…
• Atropine sulfate 0.01% opthalmic solution packaged in a squeeze bottle eye dropper…
• Atropine sulfate 0.5% opthalmic solution packaged in a squeeze bottle eye dropper…
• Atropine sulfate 1 mg/mL injectable packaged in an amber glass injectable vial, Martin…
• Atropine sulfate 2 mg/mL injectable packaged in an amber glass injectable vial, Martin…
• Bacteriostatic water for injection packaged in an amber glass injectable vial, Martin…
• Benzalkonium chloride water for injection packaged in an amber glass injectable vial…
• Bupivacaine hydrochloride 0.25% injectable packaged in an amber glass injectable…
• Calcium chloride (PF) 100 mg/mL injectable packaged in an amber glass injectable vial…

105 more are in the archive.

Where it was sold

• Nationwide

Why it was recalled

Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance.

This product could cause temporary or reversible health problems — stop using it.